Tackling Critical Catalytic Residues in Helicobacter pylori L-Asparaginase
AbstractBacterial asparaginases (amidohydrolases, EC 18.104.22.168) are important enzymes in cancer therapy, especially for Acute Lymphoblastic Leukemia. They are tetrameric enzymes able to catalyze the deamination of L-ASN and, to a variable extent, of L-GLN, on which leukemia cells are dependent for survival. In contrast to other known L-asparaginases, Helicobacter pylori CCUG 17874 type II enzyme (HpASNase) is cooperative and has a low affinity towards L-GLN. In this study, some critical amino acids forming the active site of HpASNase (T16, T95 and E289) have been tackled by rational engineering in the attempt to better define their role in catalysis and to achieve a deeper understanding of the peculiar cooperative behavior of this enzyme. Mutations T16E, T95D and T95H led to a complete loss of enzymatic activity. Mutation E289A dramatically reduced the catalytic activity of the enzyme, but increased its thermostability. Interestingly, E289 belongs to a loop that is very variable in L-asparaginases from the structure, sequence and length point of view, and which could be a main determinant of their different catalytic features. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Maggi, M.; Chiarelli, L.R.; Valentini, G.; Scotti, C. Tackling Critical Catalytic Residues in Helicobacter pylori L-Asparaginase. Biomolecules 2015, 5, 306-317.
Maggi M, Chiarelli LR, Valentini G, Scotti C. Tackling Critical Catalytic Residues in Helicobacter pylori L-Asparaginase. Biomolecules. 2015; 5(2):306-317.Chicago/Turabian Style
Maggi, Maristella; Chiarelli, Laurent R.; Valentini, Giovanna; Scotti, Claudia. 2015. "Tackling Critical Catalytic Residues in Helicobacter pylori L-Asparaginase." Biomolecules 5, no. 2: 306-317.